TapewireFind a company

person · Reporting owner

Benton Susan

Disclosed activity across 1 company

Tapewire entity
51608
SEC CIK
0001373649

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Opus Genetics, Inc.IRD · Entity 5892DirectorApril 20, 2026April 22, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Opus Genetics, Inc.

Report date April 20, 2026 · Filed April 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect243,894 Reported balance After 2026-04-20 transaction · row 1
1 source row

Row 1 · 2026-04-20 · Grant · Acquired 24,367 · Balance 243,894

F1: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 20, 2026 Filed Apr 22, 2026 20:30 UTC Opus Genetics, Inc. IRD · Entity 5892 GrantCommon Stock 24,367 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-001784 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,894

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:04 UTC Opus Genetics, Inc. IRD · Entity 5892 GrantStock Option (Right to Buy) · Derivative 79,592 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0000905148-25-001426 · form4.xml · derivative · entry 2

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,592

Underlying: Common Stock · 79,592 shares

Expires 2035-04-29

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 30, 2025 Filed May 2, 2025 21:04 UTC Opus Genetics, Inc. IRD · Entity 5892 GrantCommon Stock 79,504 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001426 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,527

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 21:25 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantStock Option (Right to Buy) · Derivative 35,181 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0000905148-24-001710 · form4.xml · derivative · entry 2

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,181

Underlying: Common Stock · 35,181 shares

Expires 2034-06-10

F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 21:25 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 41,143 $0.00 $0.00
Disclosure

SEC source: 0000905148-24-001710 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,023

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 22:57 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 19,418 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-000491 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,880

F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2024. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $2.81 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 1, 2024.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 22:48 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantStock Option · Derivative 9,639 $0.00 Strike: $3.83 $0.00
Disclosure

SEC source: 0001140361-23-029021 · form4.xml · derivative · entry 2

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,639

Underlying: Common Stock · 9,639 shares

Expires 2033-06-05

F2 · derivative.exercise_date: Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 22:48 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 10,976 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-029021 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,462

F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 19, 2023 Filed Apr 22, 2023 00:20 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 1,053 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-23-019676 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,486

F1 · price: The Reporting Person was granted shares of common stock in lieu of incremental cash amounts for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $4.27 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to April 19, 2023.

Read SEC document
January 11, 2023 Filed Jan 12, 2023 22:28 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 16,267 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-23-001504 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,433

F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $3.07 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 11, 2023.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 22:07 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 12,376 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-025289 · form4.xml · nonDerivative · entry 2

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,166

F2 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for the second half of 2022. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $2.02 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to July 1, 2022.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 22:07 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 6,335 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-025289 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,790

F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for the second quarter of 2022. The number of shares of common stock was determined by dividing (A) the aggregate amount of the retainer paid for board services for such fiscal quarter, by (B) the fair market value of the common stock on the last day of the fiscal quarter (rounded down to the nearest whole share). The fair market value was $1.92 per share, the closing price of the common stock on June 30, 2022.

Read SEC document
June 13, 2022 Filed Jun 15, 2022 20:01 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.93 $0.00
Disclosure

SEC source: 0001140361-22-023049 · form4.xml · derivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 13:16 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 3,395 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-013064 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,455

F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for the first quarter of 2022. The number of shares of common stock was determined by dividing (A) the aggregate amount of the retainer paid for board services for such fiscal quarter, by (B) the fair market value of the common stock on the last day of the fiscal quarter (rounded down to the nearest whole share). The fair market value was $3.24 per share, the closing price of the common stock on March 31, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:01 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 2,949 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-000658 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,060

F1 · price: The Reporting Person was granted common stock in lieu of cash for Q4 2021 Board services. The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share). The Fair Market Value was $3.73 per share, the closing price of the Company's stock on December 31, 2021.

Read SEC document
October 01, 2021 Filed Oct 4, 2021 20:02 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 2,135 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-21-033449 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,111

F1 · price: The Reporting Person was granted common stock in lieu of cash for Q3 2021 Board services. The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share). The Fair Market Value was $5.15 per share, the closing price of the Company's stock on September 30, 2021.

Read SEC document
September 02, 2021 Filed Sep 3, 2021 20:02 UTC Opus Genetics, Inc. OCUP · Entity 5892 PurchaseCommon Stock 20,000 $4.57 $91,400.00
Disclosure

SEC source: 0001140361-21-030364 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,976

F1 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $4.52 to $4.61. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Read SEC document
July 01, 2021 Filed Jul 2, 2021 20:02 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 2,083 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-21-023335 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,976

F1 · price: The Reporting Person was granted common stock in lieu of cash for Q2 2021 Board services. The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share). The Fair Market Value was $5.28 per share, the closing price of the Company's stock on June 30, 2021.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 22:13 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $5.74 $0.00
Disclosure

SEC source: 0001140361-21-020419 · form4.xml · derivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-07

F1 · derivative.exercise_date: Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:47 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantCommon Stock 1,893 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-21-011672 · form4.xml · nonDerivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,893

F1 · price: The Reporting Person was granted common stock in lieu of cash for Q1 2021 Board services. The number of shares of Common Stock having an aggregate fair market value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share). The Fair Market Value was $5.81 per share, the closing price of the Company's stock on March 31, 2021.

Read SEC document
November 11, 2020 Filed Nov 13, 2020 22:32 UTC Opus Genetics, Inc. OCUP · Entity 5892 GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.05 $0.00
Disclosure

SEC source: 0001140361-20-025554 · form4.xml · derivative · entry 1

Benton Susan · CIK 0001373649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-11-11

F1 · derivative.exercise_date: 16,666 shares vest each twelve month period ending October 31, 2021 and October 31, 2022 and the balance vest October 31, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.